Journals / Türk Kardiyoloji Derneği Arşivi / 2008 / Cilt: 36 - Sayı: 5

Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder in adult patients: Our first clinical experiences

Erişkin hastalarda sekundum atriyal septal defektlerin Amplatzer cihazı ile kapatılması: İlk klinik deneyimlerimiz

Pages
287–293
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Transcatheter closure of secundum ASD with the ASO device is a safe and effective method in adult patients, resulting in significant improvement in clinical symptoms and cardiac dimensions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We evaluated short-term results of transcatheter closure of secundum atrial septal defects (ASD) with the Amplatzer septal occluder (ASO) in adults.
📊
Key Findings & Data:Study design: The study included 12 patients (6 males, 6 females; mean age 31±9 years; range 17 to 54 years) who underwent transcatheter ASD closure with the ASO device.
💡
Conclusion & Impact:Conclusion: Transcatheter closure of secundum ASD with the ASO device is a safe and effective method in adult patients, resulting in significant improvement in clinical symptoms and cardiac dimensions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We evaluated short-term results of transcatheter closure of secundum atrial septal defects (ASD) with the Amplatzer septal occluder (ASO) in adults. Study design: The study included 12 patients (6 males, 6 females; mean age 31±9 years; range 17 to 54 years) who underwent transcatheter ASD closure with the ASO device. Prior to the procedure, the mean pulmonary to systemic flow ratio was 1.9±0.3 (range 1.5 to 2.6). The mean ASD diameter measured by transesophageal echocardiography was 13.9±2.8 mm, the mean stretched diameter of ASD measured by balloon sizing was 15.8±3.4 mm, and the mean ASO device diameter was 17.3±4.7 mm. The patients were evaluated before and six months after the procedure by echocardiography, electrocardiography, and the New York Heart Association (NYHA) functional classification. Results: Transcatheter ASD closure was successfully performed in 11 patients (91.7%). The mean procedure time was 72 minutes. There was no residual shunt at six months after closure. No serious complications occurred during the procedure and within a mean follow-up of 11.6±2.3 months. Echocardiographic examination at six months showed significant decreases in right ventricular end-diastolic diameter (VEDD) (p=0.007), right/left VEDD ratio (0.003), systolic pulmonary artery pressure (p=0.017), and significant increases in left ventricular ejection fraction (p=0.014) and left VEDD (p=0.005). There were significant decreases in maximum (p=0.003) and minimum (p=0.006) P-wave durations, and P-wave dispersion (p=0.028). The NYHA functional capacity improved significantly from 1.8±0.8 to 1.3±0.5 (p=0.014). Conclusion: Transcatheter closure of secundum ASD with the ASO device is a safe and effective method in adult patients, resulting in significant improvement in clinical symptoms and cardiac dimensions.

Özet

Amaç: Erişkin hastalarda, sekundum atriyal septal defektlerin (ASD) Amplatzer cihazı kullanılarak transkateter yolla kapatılmasının erken dönem sonuçları değerlendirildi. Çalışma planı: Sekundum ASD tanısıyla 12 hastaya (6 erkek, 6 kadın; ort. yaş 31±9; dağılım 17-54) Amplatzer cihazı kullanılarak ASD’nin transkateter yolla kapatılması işlemi uygulandı. İşlem öncesinde hastaların pulmoner/sistemik kan akım oranı 1.9±0.3 (dağılım 1.5-2.6) idi. Transözofajiyal ekokardiyografi ile ölçülen ASD çapı ortalama 13.9±2.8 mm, kateterde balon ile ölçülen gerilmiş ASD çapı 15.8±3.4 mm, ASD’yi kapatmak için kullanılan ortalama Amplatzer cihaz çapı 17.3±4.7 mm idi. Hastalar işlem öncesinde ve işlemden altı ay sonra ekokardiyografi, elektrokardiyografi ve New York Kalp Birliği (NYHA) fonksiyonel sınıflamasına göre değerlendirildi. Bulgular: On bir hastada (%91.7) transkateter yöntemle ASD kapatma işlemi başarıyla uygulandı. İşlem süresi ortalama 72 dk bulundu. Altıncı ay ekokardiyografik kontrolde hiçbir hastada şant izlenmedi. İşlem sırasında ve ortalama 11.6±2.3 aylık takip döneminde hiçbir hastada önemli komplikasyon gelişmedi. İşlem öncesiyle karşılaştırıldığında, altıncı ayda sağ ventrikül diyastol sonu çapı (VDSÇ) (p=0.007), sağ VDSÇ / sol VDSÇ oranı (0.003) ve sistolik pulmoner arter basıncında (p=0.017) anlamlı düşüş; sol ventrikül ejeksiyon fraksiyonu (p=0.014) ve sol VDSÇ’de (p=0.005) anlamlı artış izlendi. Altıncı aydaki elektrokardiyografide P dalga maksimum (p=0.003), minimum (p=0.006) ve dispersiyon (p=0.028) süreleri anlamlı düşüş gösterdi. Hastaların NYHA fonksiyonel sınıfı ortalama 1.8±0.8’den 1.3±0.5’e geriledi (p=0.014). Sonuç: Amplatzer cihaz yardımı ile erişkin hastalarda sekundum ASD’lerin kapatılması, belirgin klinik iyileşme ve kalp boşluk boyutlarında düzelme sağlayan uygun ve güvenilir bir yöntemdir.

🔖

Cite This Article

BAYKAN, A., İNANÇ, T., NARİN, N., TOPSAKAL, R., ÖZDOĞRU, İ., ERYOL, N. K., ÜZÜM, K., DOĞDU, O., ERGİN, A., KAYA, M. G., OĞUZHAN, A., DOĞAN, A. (2022). Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder in adult patients: Our first clinical experiences. Türk Kardiyoloji Derneği Arşivi, Cilt: 36 - Sayı: 5, 287–293. https://ajindex.com/articles/633467

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Therrien J, Webb GD. Congenital heart disease in adults. In: Braunwald E, Zipes DP, Libby P, editors. Braunwald’s heart disease: a textbook of cardiovascular medicine. 6th ed. Philadelphia: W. B. Saunders; 2001. p. 1592 621
  2. Gatzoulis MA, Redington AN, Somerville J, Shore DF. Should atrial septal defects in adults be closed? Ann Thorac Surg 1996;61:657-9
  3. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, van Domburg R, van Rijen EH, Utens EM, et al. Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years. Eur Heart J 2003;24:190-7. 4. de Lezo JS, Medina A, Romero M, Pan M, Segura J, Caballero E, et al. Effectiveness of percutaneous device occlusion for atrial septal defect in adult patients with pulmonary hypertension. Am Heart J 2002;144:877-80
  4. Pascotto M, Santoro G, Cerrato F, Caputo S, Bigazzi MC, Iacono C, et al. Time-course of cardiac remodeling following transcatheter closure of atrial septal defect. Int J Cardiol 2006;112:348-52
  5. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K; Amplatzer Investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002;39:1836-44
  6. Cowley CG, Lloyd TR, Bove EL, Gaffney D, Dietrich M, Rocchini AP. Comparison of results of closure of secundum atrial septal defect by surgery versus Amplatzer septal occluder. Am J Cardiol 2001;88:589-91
  7. Holzer R, Hijazi ZM. Interventional approach to congenital heart disease. Curr Opin Cardiol 2004;19:84-90
  8. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997;42:388-93
  9. Thanopoulos BD, Laskari CV, Tsaousis GS, Zarayelyan A, Vekiou A, Papadopoulos GS. Closure of atrial septal defects with the Amplatzer occlusion device: preliminary results. J Am Coll Cardiol 1998;31:1110-6
  10. Berger F, Ewert P, Bjornstad PG, Dahnert I, Krings G, Brilla-Austenat I, et al. Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer Septal Occluder. Cardiol Young 1999;9:468-73
  11. Losay J, Petit J, Lambert V, Esna G, Berthaux X, Brenot P, et al. Percutaneous closure with Amplatzer device is a safe and efficient